CytoMed Therapeutics Limited Ordinary Shares

Yahoo Finance • last month

Update on recent acquisition - CytoMed Therapeutics expands into auto-immune diseases building on its recent cord blood bank acquisition

SINGAPORE, Aug. 28, 2025 (GLOBE NEWSWIRE) -- CytoMed Therapeutics Limited (NASDAQ: GDTC) (“CytoMed” or “Company”), a Singapore-based clinical stage biopharmaceutical company focused on harnessing its proprietary technologies to develop n... Full story

Yahoo Finance • 2 months ago

CytoMed Therapeutics plans to raise ~$4.3M via ATM offering

* Clinical-stage biopharmaceutical company CytoMed Therapeutics (NASDAQ:GDTC [https://seekingalpha.com/symbol/GDTC]) entered into [https://seekingalpha.com/pr/20204376-cytomed-therapeutics-limited-announces-at-the-market-atm-offering-... Full story

Yahoo Finance • 2 months ago

CytoMed Therapeutics Limited Announces At-the-Market (ATM) Offering Program

SINGAPORE, Aug. 18, 2025 (GLOBE NEWSWIRE) -- CytoMed Therapeutics Limited (NASDAQ: GDTC) (“CytoMed” or “Company”), a Singapore-based clinical stage biopharmaceutical company focused on harnessing its proprietary technologies to develop n... Full story

Yahoo Finance • 3 months ago

Update On Clinical Trial Milestone - CytoMed Therapeutics Achieves Completion of Dose Level 1 of its ANGELICA TRIAL, and Proceeding to Dose Level 2 in Patients with Advanced Solid Tumors or Haematological Malignancies

SINGAPORE, July 21, 2025 (GLOBE NEWSWIRE) -- Further to our announcement filed on Form 6-K on November 20, 2024, CytoMed Therapeutics Limited (NASDAQ: GDTC) (“CytoMed” or “Company”), a Singapore-based clinical stage biopharmaceutical compa... Full story

Yahoo Finance • 4 months ago

CytoMed Therapeutics files $50M mixed shelf offering

* CytoMed Therapeutics (NASDAQ:GDTC [https://seekingalpha.com/symbol/GDTC]) may offer up to $50M in securities under a new shelf registration. * Securities may include ordinary shares, warrants, debt, rights, share purchase units, and... Full story

Yahoo Finance • 8 months ago

CytoMed Therapeutics announces Chairman’s Letter to the Company’s shareholders

SINGAPORE, Feb. 06, 2025 (GLOBE NEWSWIRE) -- CytoMed Therapeutics Limited (NASDAQ: GDTC) (“CytoMed” or the “Company”) today released a letter to shareholders from the Chairman of the Company’s Board of Directors (the “Board”) as it welco... Full story

Yahoo Finance • last year

Presenting on the Emerging Growth Conference 75 Day 2 on September 26

Emerging Growth MIAMI, Sept. 25, 2024 (GLOBE NEWSWIRE) -- EmergingGrowth.com, a leading independent small cap media portal, announces the schedule of the 75th Emerging Growth Conference on September 25 & 26, 2024. The Emerging Growth Con... Full story